YouScript Now a Verified Company with HealthXL

YouScript, a life-saving clinical decision support tool, aiding enterprise health solution providers in reducing the adverse drug event epidemic. Seattle, WA — (July 26, 2017) — YouScript is now a verified company with HealthXL , a global organization driving innovation in healthcare through an elite network of healthcare executives and global solutions. Companies can only obtain verified status when there … Read More

This Month in Pharmacogenetics and HealthIT – February 2017

Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field. While you can go and search out the news yourself, we want to make it easy for you. You can start by following social media platforms: Facebook, Twitter, Pinterest, and LinkedIn. We’re constantly posting relevant articles from around the web. Or … Read More

YouScript and Elsevier Collaborating to Incorporate Gene-based Prescribing and Reduce Alert Fatigue

Seattle, WA – YouScript and Elsevier are collaborating to bring individualized, relevant drug and dose optimization guidance to providers, pharmacists and patients wherever medication decisions are made. On February 2, 2017, Harding University published a randomized controlled trial in PLOS One in high-risk polypharmacy patients to incorporate pharmacogenetic data and YouScript’s clinical decision support system and compare results to a … Read More

New Precision Medicine Study Confirms Dramatic Reduction in Readmissions and ER Visits

Use of pharmacogenetic testing supported by an appropriate clinical decision support tool reduces mortality and overall health resource utilization in patients treated with multiple medications Seattle, WA — YouScript, a proprietary clinical decision support tool designed to assist in medication therapy management, has been shown to reduce readmissions by 52 percent (p=0.007) and ER visits by 42 percent (p=0.045) in … Read More

PSYCHIATRIC PHARMACOGENETICS from concepts to cases Book Now Available

Clinicians who treat psychiatric patients know that medications can be lifesaving, but they also know that these same potentially lifesaving psychotropic medications can have serious side effects. We now have a tool in pharmacogenetic testing that can help minimize medication side effects. Patients are increasingly requesting that their provider use this tool to help more accurately select a treatment, address … Read More

YouScript Now a Member of NAACOS

Seattle, WA— January 10, 2017 – Today, YouScript became the newest member of the National Association of ACOs (NAACOS) Business Partnership, a group of 101 businesses, organizations and vendors working to create tools that help Accountable Care Organizations (ACOs) work together to increase quality of care, lower costs, and improve the health of their communities. YouScript is excited to join … Read More

This Month in Pharmacogenetics and HealthIT – December 2016

Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field. While you can go and search out the news yourself, we want to make it easy for you. You can start by following social media platforms: Facebook, Twitter, Pinterest, LinkedIn, and our preferred lab partner, Genelex on Facebook and Twitter. We’re constantly … Read More

This Month in Pharmacogenetics and HealthIT – November 2016

Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field.  While you can go and search out the news yourself, we want to make it easy for you. You can start by following social media platforms: Facebook, Twitter, Pinterest, LinkedIn, and our preferred partner lab, Genelex on Facebook and Twitter. We’re … Read More

CYP2C19 and Clopidogrel Therapy for Stroke Patients

Key Takeaway: The use of clopidogrel plus aspirin compared with aspirin alone reduced the risk of a new stroke only in patients with normal CYP2C19 activity. This supports the findings that CYP2C19 genotype has a role in the efficacy of this treatment. Each year, approximately 795,000 people in the United States suffer a stroke and antiplatelet therapy plays a critical … Read More